Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis

J Neurol. 2019 Nov;266(11):2867-2868. doi: 10.1007/s00415-019-09483-x. Epub 2019 Jul 26.

Authors

Charlotte Rastas¹, David Sirignano², Amanda Barner², Lou Ann Bruno-Murtha³

Affiliations

¹ Department of Medicine, Cambridge Health Alliance, 1493 Cambridge Street, Cambridge, MA, 02139, USA. [email protected].
² Department of Pharmacy, Cambridge Health Alliance, 1493 Cambridge Street, Cambridge, MA, 02139, USA.
³ Department of Medicine, Cambridge Health Alliance, 1493 Cambridge Street, Cambridge, MA, 02139, USA.

PMID: 31350640
DOI: 10.1007/s00415-019-09483-x

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Dimethyl Fumarate / adverse effects*
Humans
Immunosuppressive Agents / adverse effects*
Legionellosis / diagnosis
Legionellosis / etiology*
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

Immunosuppressive Agents
Dimethyl Fumarate